Mirati Therapeutics Company Profile (NASDAQ:MRTX)

About Mirati Therapeutics

Mirati Therapeutics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $5.09
  • 50 Day Moving Average: $5.20
  • 200 Day Moving Average: $14.22
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.45
  • P/E Growth: 0.00
  • Market Cap: $101.41M
  • Outstanding Shares: 19,924,000
  • Beta: 1.33
Additional Links:
Companies Related to Mirati Therapeutics:

Analyst Ratings

Consensus Ratings for Mirati Therapeutics (NASDAQ:MRTX) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $21.63 (324.85% upside)

Analysts' Ratings History for Mirati Therapeutics (NASDAQ:MRTX)
Show:
DateFirmActionRatingPrice TargetDetails
8/18/2016Piper Jaffray Cos.Set Price TargetHold$7.00View Rating Details
6/6/2016Barclays PLCLower Price TargetOverweight$41.00 -> $27.00View Rating Details
6/6/2016Leerink SwannDowngradeOutperform -> Market Perform$37.00 -> $20.00View Rating Details
6/6/2016Citigroup Inc.Lower Price TargetBuy$30.00 -> $23.00View Rating Details
6/6/2016Jefferies GroupDowngradeBuy -> Hold$27.00 -> $17.00View Rating Details
6/6/2016WedbushLower Price TargetOutperform$29.00 -> $27.00View Rating Details
5/6/2016Avondale PartnersUpgradeMarket Perform -> Market Outperform$22.00 -> $20.00View Rating Details
3/1/2016SunTrust Banks Inc.Initiated CoverageBuy$32.00View Rating Details
6/1/2015Brean CapitalDowngradeBuy -> HoldView Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Mirati Therapeutics (NASDAQ:MRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/4/2016Q2($1.15)($1.11)ViewN/AView Earnings Details
5/5/2016Q1($0.99)($1.13)ViewN/AView Earnings Details
3/9/2016Q4($1.03)($0.96)ViewN/AView Earnings Details
11/6/2015($0.88)($1.11)ViewN/AView Earnings Details
5/6/2015($0.71)($0.77)ViewN/AView Earnings Details
3/11/2015Q414($0.83)($0.77)ViewN/AView Earnings Details
11/10/2014Q314($0.76)($0.64)ViewN/AView Earnings Details
8/8/2014Q214($0.69)($0.82)ViewN/AView Earnings Details
3/18/2014Q413($0.66)($0.97)ViewN/AView Earnings Details
11/12/2013Q313($0.78)($2.95)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mirati Therapeutics (NASDAQ:MRTX)
Current Year EPS Consensus Estimate: $-4.46 EPS
Next Year EPS Consensus Estimate: $-3.5 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($1.19)($0.90)($1.01)
Q2 20165($1.21)($1.00)($1.08)
Q3 20165($1.22)($1.02)($1.10)
Q4 20165($1.22)($0.91)($1.03)
Q1 20171($1.08)($1.08)($1.08)
Q2 20171($1.10)($1.10)($1.10)
Q3 20171($1.12)($1.12)($1.12)
Q4 20171($1.16)($1.16)($1.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mirati Therapeutics (NASDAQ:MRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (NASDAQ:MRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2016Charles M BaumCEOBuy20,000$7.05$141,000.00View SEC Filing  
6/9/2016Bros. Advisors Lp BakerMajor ShareholderSell999,358$9.41$9,403,958.78View SEC Filing  
6/7/2016Ltd. BraslynMajor ShareholderBuy376,902$9.96$3,753,943.92View SEC Filing  
5/6/2016Ltd. BraslynMajor ShareholderBuy65,782$18.21$1,197,890.22View SEC Filing  
3/28/2016Ltd. BraslynMajor ShareholderBuy20,848$19.36$403,617.28View SEC Filing  
3/18/2016Ltd. BraslynMajor ShareholderBuy1,166$19.34$22,550.44View SEC Filing  
1/15/2016Mark J. GergenCOOSell10,000$25.92$259,200.00View SEC Filing  
9/16/2015Bros. Advisors Lp BakerMajor ShareholderBuy150,000$45.00$6,750,000.00View SEC Filing  
5/26/2015Jamie ChristensenSVPSell4,750$28.07$133,332.50View SEC Filing  
3/5/2015Jamie ChristensenSVPSell6,000$25.41$152,460.00View SEC Filing  
2/19/2015Jamie ChristensenSVPSell4,750$22.84$108,490.00View SEC Filing  
2/3/2015Orbimed Advisors LlcMajor ShareholderBuy100,000$20.00$2,000,000.00View SEC Filing  
1/29/2015Bros. Advisors Lp BakerMajor ShareholderBuy425,000$20.00$8,500,000.00View SEC Filing  
7/1/2014Orbimed Advisors LlcMajor ShareholderSell107,332$21.66$2,324,811.12View SEC Filing  
11/26/2013Charles M BaumCEOBuy5,000$16.96$84,800.00View SEC Filing  
10/29/2013Orbimed Advisors LlcMajor ShareholderBuy125,000$17.50$2,187,500.00View SEC Filing  
10/24/2013Tang Capital Partners LpMajor ShareholderBuy57,143$17.50$1,000,002.50View SEC Filing  
9/20/2013Tang Capital Partners LpMajor ShareholderSell36,898$16.34$602,913.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mirati Therapeutics (NASDAQ:MRTX)
DateHeadline
investornewswire.com logoWill Mirati Therapeutics, Inc. (NASDAQ:MRTX) Hit $17 Price Target? - Investor Newswire (NASDAQ:MRTX)
www.investornewswire.com - August 16 at 9:35 AM
finance.yahoo.com logoMIRATI THERAPEUTICS, INC. Financials (NASDAQ:MRTX)
finance.yahoo.com - August 12 at 6:21 PM
thestreet.com logo7 Stocks Under $10 Making Big Up Moves (NASDAQ:MRTX)
www.thestreet.com - August 12 at 9:31 AM
twst.com logoMirati Therapeutics Inc.: Mirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016 (NASDAQ:MRTX)
www.twst.com - August 4 at 6:38 PM
finance.yahoo.com logoMirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016 (NASDAQ:MRTX)
finance.yahoo.com - August 4 at 6:38 PM
sg.finance.yahoo.com logoMirati reports 2Q loss (NASDAQ:MRTX)
sg.finance.yahoo.com - August 4 at 6:38 PM
equities.com logoMirati Therapeutics Inc. (MRTX) is Trading Higher on Unusual Volume for August 01 - Equities.com (NASDAQ:MRTX)
www.equities.com - August 3 at 9:35 AM
equities.com logoMirati Therapeutics Inc. (MRTX) Drops 5.79% on July 28 - Equities.com (NASDAQ:MRTX)
www.equities.com - July 30 at 5:43 PM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 28 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - July 30 at 5:43 PM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 25 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - July 27 at 6:37 PM
ftsenews.co.uk logoNew Broker Ratings For Mirati Therapeutics, Inc. (MRTX) - FTSE News (NASDAQ:MRTX)
www.ftsenews.co.uk - July 22 at 9:15 AM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 20 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - July 22 at 9:15 AM
biz.yahoo.com logoMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MRTX)
biz.yahoo.com - July 21 at 4:04 PM
equities.com logoMirati Therapeutics Inc. (MRTX) Drops 6.37% on July 19 - Equities.com (NASDAQ:MRTX)
www.equities.com - July 21 at 9:08 AM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 19 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - July 21 at 9:08 AM
investornewswire.com logoIs $32 Price Target Attainable For Mirati Therapeutics, Inc. (NASDAQ:MRTX)? - Investor Newswire (NASDAQ:MRTX)
www.investornewswire.com - July 20 at 7:00 PM
News IconIs Selling Stock Like Mirati Therapeutics, Inc. After Such Decline Winning Strategy? - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - July 20 at 6:59 PM
insidermonkey.com logo10 Battered Biotech Stocks That Hit 52-Week Lows Friday (NASDAQ:MRTX)
www.insidermonkey.com - July 18 at 11:05 AM
News IconVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Consumer Eagle (NASDAQ:MRTX)
www.consumereagle.com - July 17 at 10:34 AM
News IconShares Moving Down on the Week: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - July 17 at 10:34 AM
News IconShares Experiencing a Downtrend: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - TGP (NASDAQ:MRTX)
telanaganapress.com - July 16 at 9:38 AM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 14 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - July 16 at 9:38 AM
News IconIncreased Volatility Noted on Shares of: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - July 15 at 5:20 PM
News IconMirati Therapeutics Incorporated (NASDAQ:MRTX) Shorted Shares Increased 28.48% After Market Selling - Consumer Eagle (NASDAQ:MRTX)
www.consumereagle.com - July 15 at 5:20 PM
News IconMirati Therapeutics, Inc. Just Reaches All-Time Low? - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - July 15 at 10:49 AM
equities.com logoMirati Therapeutics Inc. (MRTX) Drops 5.4% on July 13 - Equities.com (NASDAQ:MRTX)
www.equities.com - July 14 at 6:31 PM
fiscalstandard.com logoBroker Outlook For Mirati Therapeutics, Inc. (MRTX) - Fiscal Standard (NASDAQ:MRTX)
www.fiscalstandard.com - July 14 at 9:53 AM
News IconStock Volatility Focus for: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - July 12 at 10:38 AM
News IconMirati Therapeutics Incorporated (NASDAQ:MRTX) Short Interest Increased By 28.48% - Consumer Eagle (NASDAQ:MRTX)
www.consumereagle.com - July 12 at 10:38 AM
investornewswire.com logoStrong Sell Calls For Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 0 - Investor Newswire (NASDAQ:MRTX)
www.investornewswire.com - July 12 at 10:38 AM
fiscalstandard.com logoMirati Therapeutics, Inc. (MRTX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:MRTX)
www.fiscalstandard.com - July 12 at 10:38 AM
News IconCan Mirati Therapeutics, Inc. (NASDAQ:MRTX) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - July 6 at 6:32 PM
News IconMirati Therapeutics Incorporated (NASDAQ:MRTX) Short Interest Increased By 28.48% - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - July 1 at 6:18 PM
News IconInvestor News: Mirati Therapeutics, Inc. (NASDAQ:MRTX) under Investigation over possible Violations of Securities Laws - GroundReport (NASDAQ:MRTX)
www.groundreport.com - July 1 at 6:18 PM
News IconShares Entering Oversold Territory: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - July 1 at 6:18 PM
News IconVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - July 1 at 6:18 PM
fiscalstandard.com logoMirati Therapeutics, Inc. (MRTX) Current Analyst Ratings - Fiscal Standard (NASDAQ:MRTX)
www.fiscalstandard.com - July 1 at 6:18 PM
forbes.com logoBiotech's Top 5 Losers, and Winners, From Q2 2016 (NASDAQ:MRTX)
www.forbes.com - June 30 at 6:38 PM
4-traders.com logoMirati Therapeutics : Announces Change In Executive Leadership (NASDAQ:MRTX)
www.4-traders.com - June 30 at 6:38 PM
News IconInvestor News: Mirati Therapeutics, Inc. (NASDAQ:MRTX) under Investigation over possible Violations of Securities Laws (NASDAQ:MRTX)
www.groundreport.com - June 29 at 6:10 PM
News IconCovering the Bases on Mirati Therapeutics, Inc. (NASDAQ:MRTX): Where is the Stock Going? - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - June 28 at 11:07 AM
investornewswire.com logoStrong Sell Calls Recommendations For Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 0 - Investor Newswire (NASDAQ:MRTX)
www.investornewswire.com - June 28 at 11:07 AM
News IconVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - June 25 at 10:03 AM
News IconStock in Oversold Area: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Press Telegraph (NASDAQ:MRTX)
presstelegraph.com - June 24 at 6:14 PM
News IconHow Many Mirati Therapeutics, Inc. (NASDAQ:MRTX)'s Analysts Are Bearish? - Engelwood Daily (NASDAQ:MRTX)
www.engelwooddaily.com - June 24 at 6:14 PM
News IconFrontline Trades in Focus: American Express (NYSE:AXP), Mirati Therapeutics (NASDAQ:MRTX), Diamondrock ... - Seneca Globe (NASDAQ:MRTX)
www.senecaglobe.com - June 23 at 6:46 PM
news.cmlviz.com logoMirati Therapeutics, Inc. (NasdaqCM:MRTX) Stock Momentum Hits EXTREME Weakness - CML News (NASDAQ:MRTX)
news.cmlviz.com - June 23 at 6:46 PM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 20 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - June 23 at 6:46 PM
streetinsider.com logoMirati Therapeutics (MRTX) COO to Step Down - StreetInsider.com (NASDAQ:MRTX)
www.streetinsider.com - June 23 at 6:46 PM
equities.com logoMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 21 Session - Equities.com (NASDAQ:MRTX)
www.equities.com - June 23 at 6:46 PM

Social

Mirati Therapeutics (NASDAQ:MRTX) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff